• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New prostate cancer grade group system correlates with prostate cancer death in addition to biochemical recurrence.

作者信息

Epstein Jonathan I

机构信息

Department of Pathology, Urology, Oncology, The Reinhard Professor of Urological Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231-241, USA.

出版信息

Br J Cancer. 2016 May 10;114(10):1069-70. doi: 10.1038/bjc.2016.102.

DOI:10.1038/bjc.2016.102
PMID:27167449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4865965/
Abstract
摘要

相似文献

1
New prostate cancer grade group system correlates with prostate cancer death in addition to biochemical recurrence.新的前列腺癌分级组系统除了与生化复发相关外，还与前列腺癌死亡相关。
Br J Cancer. 2016 May 10;114(10):1069-70. doi: 10.1038/bjc.2016.102.
2
Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.根治性前列腺切除术后前列腺特异性抗原复发时间与前列腺癌特异性死亡风险
J Urol. 2006 Oct;176(4 Pt 1):1404-8. doi: 10.1016/j.juro.2006.06.017.
3
Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.前列腺特异性抗原水平、分期或 Gleason 评分：哪一项最适合预测根治性前列腺切除术后的结果，并且它是否因所测量的结果而异？来自共享平等访问区域癌症医院数据库的结果。
Int J Urol. 2015 Apr;22(4):362-6. doi: 10.1111/iju.12704. Epub 2015 Feb 24.
4
Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy.对采用根治性前列腺切除术治疗的达米科中度风险前列腺癌生化复发危险因素的重新评估。
Int J Urol. 2015 Nov;22(11):1029-35. doi: 10.1111/iju.12898. Epub 2015 Aug 20.
5
Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?超敏前列腺特异性抗原检测在预测前列腺癌根治术后男性长期无生化复发生存方面有作用吗？
J Urol. 2016 Feb;195(2):330-6. doi: 10.1016/j.juro.2015.08.080. Epub 2015 Aug 22.
6
Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.通过超敏检测法测得的血清前列腺特异性抗原最低点值作为临床局限性前列腺癌根治性前列腺切除术后生化复发预测指标的实用性。
Urol Int. 2006;76(3):227-31. doi: 10.1159/000091624.
7
Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapy.前列腺切除术后超敏前列腺特异性抗原能可靠地识别需要术后放疗的患者。
J Urol. 2015 May;193(5):1532-8. doi: 10.1016/j.juro.2014.11.017. Epub 2014 Nov 14.
8
Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?对于局限性前列腺癌，耻骨后根治性前列腺切除术后，术前血清前列腺特异性抗原水平与临床复发是否显著相关？
BJU Int. 2006 Jan;97(1):51-5. doi: 10.1111/j.1464-410X.2006.05886.x.
9
Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database.前列腺癌根治术后前列腺特异性抗原持续升高的自然病程：来自SEARCH数据库的结果
J Urol. 2009 Nov;182(5):2250-5. doi: 10.1016/j.juro.2009.07.022. Epub 2009 Sep 16.
10
What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.根治性前列腺切除术后前列腺特异性抗原倍增时间短与哪些因素相关？来自SEARCH数据库小组的报告。
J Urol. 2008 Nov;180(5):1980-4; discussion 1985. doi: 10.1016/j.juro.2008.07.031. Epub 2008 Sep 17.

引用本文的文献

1
Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings.根据新的前列腺癌分级分组，澳大利亚队列的肿瘤学结果。
BMC Cancer. 2017 Aug 10;17(1):537. doi: 10.1186/s12885-017-3533-9.
2
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians.前列腺癌的当代分级：2017年病理学家和临床医生更新版
Asian J Androl. 2017 Aug 4;21(1):19-23. doi: 10.4103/aja.aja_24_17.

本文引用的文献

1
Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome.以前列腺癌死亡为结局对当代前列腺癌分级系统进行验证。
Br J Cancer. 2016 May 10;114(10):1078-83. doi: 10.1038/bjc.2016.86. Epub 2016 Apr 21.
2
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.2014年国际泌尿病理学会（ISUP）前列腺癌Gleason分级共识会议：分级模式的定义及新分级系统的建议
Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530.
3
Prostate biopsy and radical prostatectomy Gleason score correlation in heterogenous tumors: proposal for a composite Gleason score.前列腺穿刺活检与根治性前列腺切除术在异质性肿瘤中的 Gleason 评分相关性：复合 Gleason 评分的建议。
Am J Surg Pathol. 2015 Sep;39(9):1213-8. doi: 10.1097/PAS.0000000000000499.
4
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.一种当代前列腺癌分级系统：格里森评分的有效替代方案。
Eur Urol. 2016 Mar;69(3):428-35. doi: 10.1016/j.eururo.2015.06.046. Epub 2015 Jul 10.
5
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.预后格里森分级分组：基于改良格里森评分系统的数据。
BJU Int. 2013 May;111(5):753-60. doi: 10.1111/j.1464-410X.2012.11611.x. Epub 2013 Mar 6.